Health

Africa CDC talking to Pfizer about importing its COVID-19 treatment pill

Africa’s top public health body is in talks with Pfizer about bringing in supplies of its antiviral Paxlovid treatment pills for COVID-19 to the continent, its director said on Thursday.

Paxlovid was nearly 90 percent effective in preventing hospitalizations and deaths, and data suggested it retains its effectiveness against omicron, Pfizer has said.

For more coronavirus news, visit our dedicated page.

“We are in really close discussions with Pfizer to see what can be done to make the drugs available on the continent and accessible on the continent, that is the Paxlovid drugs,” said John Nkengasong, director of the Africa Centers for Disease Control.

Governments around the world are scrambling to buy Paxlovid, while Merck’s Molnupiravir has faced setbacks after disappointing trial data.

For the latest headlines, follow our Google News channel online or via the app.

Nkengasong said that obtaining supplies of COVID-19 drugs was one of three key strategies for combating the pandemic in Africa in 2022, along with scaling up vaccinations and expanding testing.

Drugs for treating COVID-19 would be crucial in the eventuality of another highly transmissible variant emerging and public health systems becoming overwhelmed, he said.

“The only way to relieve that will be if we have drugs like Paxlovid where people can take that drug and stay home and get relief, and that way the burden and the constraints on the health system will be limited,” Nkengasong told an online news briefing.

“That’s why we are working on those three things this year very, very actively,” he said.

Africa has officially recorded just over 10 million cases of COVID-19 since the start of the pandemic, although the real number is likely much higher due to patchy testing.

Several African countries are going through fourth or fifth waves of infections.

Nkengasong said 10 percent of Africans were fully vaccinated.

South Korea will begin treating COVID-19 patients with Paxlovid on Friday, the first Asian country to do so.

Poorer nations reject over 100 million COVID-19 shots as many close to expiry

Pfizer study shows COVID-19 booster can be given along with pneumonia shot

Health

‘Just in case’ use of antibiotics was rife during COVID-19, says UN health agency

Antibiotics saw “extensive overuse” globally among hospitalized COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially exacerbating the already serious and growing threat of antimicrobial resistance, the UN World Health Organization (WHO) said on Friday.

Health

Teen alcohol and nicotine use in Europe is up, WHO urges preventive measures

Substance use is on the rise among teenagers in Europe, Central Asia and Canada and girls now match or even exceed boys when it comes to smoking and drinking, the World Health Organization (WHO) said in a new report on Thursday.

Health

Gender therapy review reveals devastating impacts on teens

A top Human Rights Council-appointed expert has welcomed the decision by all health authorities in the United Kingdom to halt the routine use of puberty-blockers offered to children as part of gender transition services, amid a sharp increase more widely in the number of teenage girls seeking such treatment and concerns that it might disrupt brain development.